Skip to search formSkip to main contentSkip to account menu

Licarbazepine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Objective: Determine the pharmacokinetic profile of Oxtellar XR by measuring LCBZ (synonym: 10-monohydroxy derivative, MHD) and… 
2014
2014
The present work describes, for the first time, the simultaneous separation of oxcarbazepine (OXC) and its active metabolite 10… 
Review
2012
Review
2012
Epilepsy is one of the most common neurological diseases. In recent years an important number of drugs have been added to the… 
2010
2010
Racemic licarbazepine (Lic) is the active metabolite of oxcarbazepine (OXC) and eslicarbazepine acetate (ESL), appearing in human… 
2008
2008
Two studies characterized single‐ and multiple‐dose pharmacokinetics of licarbazepine immediate‐release tablets and food effects… 
2008
2008
AbstractObjective: To investigate the dosage form proportionality and food effect of the final tablet formulation of… 
2005
2005
The present invention, as the pharmaceutical substance 10,11-dihydro-10-hydroxy -5H- dibenzo [b, f] relates to a pharmaceutical…